Sort
3,198 grants matching “mrna vaccine”
COVID-19: immune response and systems vaccinology
$3,036,975Lothar Hennighausen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
The Genome Analysis Core
$3,017,558Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIC · FY2021 · AI
Design of single-shot sequential immunization regimens for HIV using atomic layer deposition technology.
$3,017,032Darrell J Irvine · Scripps Research Institute, The · R01 · FY2025 · AI
Graft-versus-leukemia
$3,005,624Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL
Unravelling immunoregulatory circuits of tissue inflammation
$3,000,357Behdad Afzali · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Project 5: mRNA and mRNA-launched nanoparticle vaccines
$2,913,088Neil King · University Of Washington · U19 · FY2024 · AI
Immune signatures of vaccine responses in vulnerable populations
$2,874,261Ruth R Montgomery · Yale University · U19 · FY2022 · AI
Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19
$2,863,199Carl H. June · University Of Pennsylvania · P01 · FY2025 · CA
Design and evaluation of pan-CoV vaccines
$2,819,456Yoshihiro Kawaoka · University Of Wisconsin-Madison · P01 · FY2023 · AI
Core 3: Non-human Primate Core
$2,798,848Barton F Haynes · Duke University · P01 · FY2023 · AI
Eliciting neutralizing antibodies and B cell responses using novel HIV Env immunogens in non-human primates
$2,794,109Richard Thomas Wyatt · Scripps Research Institute, The · P01 · FY2025 · AI
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$2,767,364Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
The Genome Analysis Core
$2,751,570Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIC · FY2025 · AI
Project 2: Development of vaccines in preclinical models to induce V2-apex bnAb responses
$2,750,363George M Shaw · University Of Pennsylvania · U19 · FY2025 · AI
Nucleic acid vaccines targeting hantaviruses
$2,727,988Alexander Bukreyev · Vanderbilt University Medical Center · U19 · FY2024 · AI
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$2,719,866Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
The Development and Evaluation of Pan-Coronavirus Vaccines
$2,716,452Michael S. Diamond · Washington University · P01 · FY2025 · AI
Regulation of innate immunity by self-adjuvated MRNA vaccines
$2,710,680Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2025 · AI
Immune signatures of vaccine responses in vulnerable populations
$2,706,289Ruth R Montgomery · Yale University · U19 · FY2023 · AI
Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogens
$2,635,377Christopher Parks · International Aids Vaccine Initiative · P01 · FY2018 · AI
Advancement of a poxvirus antiviral
$2,607,328John H Connor · Boston University Medical Campus · R01 · FY2025 · AI
Discovery of Adjuvants for mRNA Vaccines
$2,601,750Dennis Carson · University Of California, San Diego · N01 · FY2024 · AI
Development of rationally designed HIV vaccines
$2,580,801Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$2,561,153Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Search for the Structural Basis of Biomacromolecular Function and Activity
$2,560,874Yun Xing M Wang · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA